Large-scale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas

Human Pathology

Volumn 34, Issue 6, 2003, Pages 605-609

  Frierson Jr , Henry F ^a   Moskaluk, Christopher A ^b   Powell, Steven M ^b   Zhang, Hong ^b   Cerilli, Lisa A ^b   Stoler, Mark H ^b   Cathro, Helen ^b   Hampton, Garret M ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b NONE

Author keywords

Carcinoma; Gene expression; Immunohistochemistry; Mesothelin; Microarray

Indexed keywords

GLYCOPROTEIN; IMMUNOTOXIN; MESOTHELIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; CARCINOMA; DNA MICROARRAY; EPITHELIUM CELL; FROZEN SECTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MEGAKARYOCYTE; MESOTHELIOMA; MOLECULAR LIBRARY; PROTEIN EXPRESSION; TISSUE SECTION;

EID: 0038207068     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(03)00177-1     Document Type: Article

References (22)

1. Kojima T, Oh-eda M, Hattori K, et al: Molecular cloning and expression of megakaryocyte potentiating factor cDNA. J Biol Chem 270:21984-21990, 1995
2. Chang K, Pastan I: Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc Natl Acad Sci U S A 93:136-140, 1996
3. Bera TK, Pastan I: Mesothelin is not required for normal mouse development or reproduction. Mol Cell Biol 20:2902-2906, 2000
4. Chang K, Pastan I, Willingham MC: Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium. Int J Cancer 50:373-381, 1992
5. Chang K, Pai LH, Pass H, et al: Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma. Am J Surg Pathol 16:259-268, 1992
6. Argani P, Iacobuzio-Donahue C, Ryu B, et al: Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: Identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res 7:3862-3868, 2001
7. Hough CD, Sherman-Baust CA, Pizer ES, et al: Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 60:6281-6287, 2000
8. Hippo Y, Yashiro M, Ishii M, et al: Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Res 61:889-895, 2001
9. Wang K, Gan L, Jeffery E, et al: Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene 229:101-108, 1999
10. Brinkmann U, Webber K, Di Carlo A, et al: Cloning and expression of the recombinant Fab fragment of monoclonal antibody K1 that reacts with mesothelin present on mesotheliomas and ovarian cancers. Int J Cancer 71:638-644, 1997
11. Chang K, Pastan I: Molecular cloning and expression of a cDNA encoding a protein detected by the K1 antibody from an ovarian carcinoma (OVCAR-3) cell line. Int J Cancer 57:90-97, 1994
12. Bhattacharjee A, Richards WG, Staunton J, et al: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 98:13790-13795, 2001
13. Scholler N, Fu N, Yang Y, et al: Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma. Proc Natl Acad Sci U S A 96:11531-11536, 1999
14. Chang K, Pastan I, Willingham MC: Frequent expression of the tumor antigen CAK1 in squamous-cell carcinomas. Int J Cancer 51:548-554, 1992
15. Su AI, Welsh JB, Sapinoso LM, et al: Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 61:7388-7393, 2001
16. Welsh JB, Sapinoso LM, Su AI, et al: Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 61:5974-5978, 2001
17. Lockhart DJ, Dong H, Byrne MC, et al: Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14:1675-1680, 1996
18. Wodicka L, Dong H, Mittmann M, et al: Genome-wide expression monitoring in Saccharomyces cerevisiae. Nat Biotechnol 15:1359-1367, 1997
19. Silver SA, Askin FB: True papillary carcinoma of the lung. A distinct clinicopathologic entity. Am J Surg Pathol 21:43-51, 1997
20. Su AI, Cooke MP, Ching KA, et al: Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci U S A 99:4465-4470, 2002
21. Hassan R, Viner JL, Wang QC, et al: Anti-tumor activity of K1-LysPE38QQR, an immunotoxin targeting mesothelin, a cell-surface antigen overexpressed in ovarian cancer and malignant mesothelioma. J Immunother 23:473-479, 2000
22. Hassan R, Lerner MR, Benbrook D, et al: Antitumor activity of SS(dsFv)PE38 and SS1(dsFv)PE38, recombinant antimesothelin immunotoxins against human gynecologic cancers grown in organotypic culture in vitro. Clin Cancer Res 8:3520-3526, 2002